Mission statement
The UK and Ireland Global Cancer Network (UKIGCN) is the independent not-for-profit network of individuals and institutions based in UK and Ireland based committed to working in partnership with colleagues in low- and middle-income countries (LMICs).
The mission of the UKIGCN is to bring together the talent, resources and enthusiasm of these individuals and organisations in a strategic and collaborative body in ways that improve the outcome and experience of populations affected by cancer in LMICs.
The principal objectives of the UKIGCN are:
- To serve as a liaison point for a UK and Ireland cadre of Active Members and Supporters committed to working collaboratively with LMIC partners in cancer care
- To raise awareness by engaging with UK and Ireland professionals, policymakers and the public about the worsening cancer burden in LMIC and how, through working in partnership with LMIC colleagues, together we can have a significant positive impact
- To act as a catalyst for new UK and Ireland/ LMIC partnerships that contribute to sustainable improvements in cancer prevention, diagnosis, treatment and research that benefit populations in poorer resourced settings.
Our Steering group

Mark Lodge
Mark Lodge is a consultant systematic reviewer specializing in cancer and Chair of the UKIGCN Steering Committee. He has provided technical advice to the NHS, European Investment Bank and the Commonwealth Secretariat and was the International Network for Cancer Treatment and Research’s UK Executive Director 2008- 2024. He is the commissioning editor for the annual Cancer Control published by Global Health Dynamics, a member of the Lancet Oncology Commission on Cancer in the Commonwealth, and between 2019-2023 was the creator and Convenor of London Global Cancer Week.

Dr Susannah Stanway MBChB MSc FRCP MD
Dr Susannah Stanway is an honorary consultant medical oncologist at the Royal Marsden Hospital in the UK, specializing in breast cancer with an interest in global cancer care and has an associate honorary faculty position at the Institute of Cancer Research (ICR). She is a past president of the Oncology Section of the Royal Society of Medicine where she founded and chaired the steering group of the “Cancer control in low- and middle- income countries” conference held annually between November 2016-2018 and now co-convenes London Global Cancer Week. She teaches about global cancer control on several post-graduate courses in the UK (for example on the Institute of Cancer Research MSc Course, UCL Global Health MSc and London School of Hygiene and Tropical Medicine on the Diploma of Tropical Medicine and Hygiene Course) and speaks nationally and internationally. She has received three awards from the Global Challenges Research Fund to collaboratively contribute to research projects in sub-Saharan Africa and is on the editorial board of eCancer. She is in the ECO inequalities network, has historically been on the ESMO global policy committee and is on the ASCO International Affairs Committee.
She is currently working with colleagues in several conflict affected, fragile and low-income settings to contribute to capacity building for cancer care. She is interested in the nexus of climate change and health and chairs the international affairs group of Oncology Advocates United for Climate and Health (OUCH). She has recently studied Public Policy Analysis at the London School of Economics. Alongside reducing between-country cancer outcome inequalities she has interest in reducing within-country inequalities in the UK for example sitting on Breast Cancer Now Improving Public Health, Equity and Wellbeing Committee. She sits on the Development Board of Breast Cancer Now. She lives in London with her husband and four children.

Annie Young
Annie Young is Emerita Professor of Nursing at Warwick Medical School, University of Warwick and Honorary Nurse Consultant, University Hospitals Coventry and Warwickshire. Annie works part-time at the University, striving to build global nursing research capacity in supportive care for people with cancer and their caregivers.
Educationally, her focus is on training and exchange programmes in cancer nursing care between the University and sub-Saharan African countries and other international collaborators. Annie co-leads the Global Power of Oncology Nursing webinars as part of London Global Cancer Week.

Dr Bhawna Sirohi
Dr Bhawna Sirohi is currently working as the Lead Medical Oncologist at Apollo Proton Cancer Centre, Chennai. She has previously worked at renowned cancer centres in UK and India including Royal Marsden NHS Foundation Trust, The Barts Health NHS Trust, Addenbrookes NHS Foundation Trust, Guys & St Thomas’ NHS trust; Tata Memorial Centre, Mumbai; Max Cancer Centre, Delhi, Artemis Health care, Gurgaon; Narayana Health, Bangalore. She has more than two decades of experience as a medical oncologist. She has published more than 120 papers in national and international journals and lectured worldwide. She is the immediate past -President of the Oncology section of the Royal Society of Medicine.
She has a keen interest in developing cancer care in LMICs which is cost-effective and quality driven. She has been involved in the initial set-up of cancer centres in India for both the public and private sectors. She is the Secretary of the EBMT Nuclear Accident Committee. She is the founder and President of the New India Cancer charity Initiative which has led in clinical screening in rural India.

Pia Delano Baudet

Professor David Weakliam
Professor Weakliam is a Consultant in Public Health Medicine and Director of the Global Health Programme in the Irish Health Service Executive (HSE). He has worked in global health for more than 35 years, including 12 years in Nepal, Liberia, Sudan, DR Congo and Ghana. In his current role he leads HSE partnerships for health service improvement with Ministries of Health in Mozambique, Ethiopia, Tanzania, Sudan and Zambia.
He also collaborates with the Irish Global Health Network to implement ESTHER Ireland, a programme facilitating and supporting twinning partnerships by Irish health services and institutions with counterparts in more than 20 countries in Africa and Asia. He is Adjunct Professor at University College Dublin.

Dr Katy Piddock
Dr Katy Piddock is a specialist registrar training to be a clinical oncologist in Liverpool, UK. She is passionate about delivering high quality radiotherapy and systemic therapy both in the UK and abroad. She has completed a diploma at the London School of Hygiene and Tropical Medicine and also spent time at WHO headquarters in Geneva.
An advocate for the field of global cancer care, Katy founded and hosted the Global Oncology Podcast, including interviews recorded whilst at the cancer centre in Mwanza, Tanzania.

Kirsten Hopkins
Kirsten Hopkins worked as a Clinical Oncologist in Bristol, specializing in neuro-oncology and colorectal cancer. In addition to her routine clinical practice, she established a stereotactic service, served as a Training Program Director, led the neuro-oncology trials program and taught oncology in Mbarara in Uganda, latterly chairing the steering committee for the hospital link. In 2012, she helped to establish the first Government oncology clinic and chemotherapy service for adults in Uganda outside Kampala. However, this experience highlighted the tragic dearth of radiotherapy services in low and middle income countries, particularly when considered in relation to the casemix who can benefit from the treatment.
This led Kirsten to move in 2014, to a post with the International Atomic Energy Agency (IAEA), where she advised on more than fifty radiotherapy development projects, principally in Africa and Central Asia. In addition, she co-ordinated international working parties to write consensus documents for the IAEA website and implemented clinical research projects in middle income countries, to address relevant questions and bring emerging centres into the research community.
Since 2021, Kirsten has undertaken individual missions for the IAEA to provide reports related to cancer service planning, and has worked with Dr Aileen Flavin to implement a project to strengthen paediatric radiotherapy services in Nepal. She is a member of the steering group of the UK and Ireland Global Cancer Network.

Netty Cracknell MPharm, Dip, Msc, fBOPA, FRPharmS (IP) President ISOPP (2024-2026)
Netty Cracknell is a senior cancer pharmacist and a recognised national leader in systemic anti-cancer therapy, with over 20 years’ experience transforming cancer services across the NHS and independent sectors. A Fellow of the British Oncology Pharmacy Association and the Royal Pharmaceutical Society, and the current President of the International Society of Oncology Pharmacy Practitioners (ISOPP), she brings extensive expertise in SACT governance, protocol development, digital innovation, and collaborative leadership.
Keen to serve as a Steering Group representative for the UK and Ireland Global Cancer Network, Netty is committed to ensuring that the pharmacy perspective underpins safe, equitable, and patient-centred cancer care. She aims to actively contribute to the network’s mission to share knowledge and develop best pharmacy practice in cancer care globally, ensuring that safe and effective medicines use remains at the heart of service improvement and patient outcomes.

Dr Hannah Lyons
Dr Hannah Lyons is an Oncology Registrar. She is currently working in the Severn Deanery in the south west of England. Prior to this she has worked in London and across the south west, and has worked and studied internationally in Belgium and South Africa.
She is a co-founder of the Future Global Cancer Leaders Oncology UK and Ireland and is passionate about global cancer care and equity in medicine.

Ms Louise Murphy
Louise is a senior research officer at the National Cancer Control Programme of Ireland. Louise brings particular expertise in program management and guideline development. In recent times, Louise has founded Future Global Cancer Leaders UK & Ireland, together with Hannah Lyons and Katy Piddock. This group aims to connect, learn and advocate in the field of global cancer care.
Advisory Board
The UK & Ireland Global Cancer Network is honoured to recognise the following as our Advisory Board and Founding Members (F):
- Kenneth Fleming, FRCPath, DPhil – (F)
- Katherine Piddock, MBChB, MRCP, BMedSci (Hons), DTM&H – (F)
- Hedley Glencross, Chartered Scientist, Fellow Institute of Biomedical Science – (F)
- Tim Eden, MB BS, D(Obst)RCOG London, MRCP(UK), FRCPE( Edinburgh), FRCP London, FRC Path, FRCPCH(Founding member), FRCR – (F)
- Mai Bishr, MBBCH, MSc clinical oncology – (F)
- David Collingridge, Editor-in-Chief & Publisher at The Lancet Oncology – (F)
- Anguraj Sadanandam, PhD – (F)
- Mary Taj, MBBS, DCH, MRCP(ch), FRCP (ch) – (F)
- Chloe Tuck, MBiochem, PhD – (F)
- Georgina Wood, MBBS BSc MSc PhD – (F)
- Pippa Lewis, MBBS MSc MRCP FRCR – (F)
- Charlotte Ashton, Communications and External Engagement Manager at THET – (F)
- Richard Sullivan Director, Institute of Cancer Policy and Co-Director of the Centre for Conflict & Health Research – (F)
- Rebecca Morton-Doherty, Director, Policy and Impact at City Cancer Challenge – (F)
- Jon Rosser, Chief Executive of World Child Cancer – (F)
- Kathy Pritchard-Jones, President of SIOP and Professor of Paediatric Oncology – (F)
- Ros Eeles, FMedSci, PhD, FRCP, FRCR – (F)
- Emma Foreman, Consultant Pharmacist – (F)
- Susan Henshall, PhD, MPH, Chief Executive Officer of City Cancer Challenge – (F)
- Claire Morris, Director of Advocacy at The Worldwide Hospice Palliative Care Alliance – (F)
- Claudia Allemani, MSc, PhD, FHEA, MFPH – (F)